首页> 外文期刊>Journal of Krishna Institute of Medical Sciences University. >Prevalence and Fluoroquinolone Resistance Pattern in Escherichia coli Isolates of Urinary Tract Infection (UTI) Patients .
【24h】

Prevalence and Fluoroquinolone Resistance Pattern in Escherichia coli Isolates of Urinary Tract Infection (UTI) Patients .

机译:尿路感染(UTI)患者大肠杆菌分离物的流行和氟喹诺酮耐药模式。

获取原文
           

摘要

Background: Urinary tract infections (UTIs) are among the most common infectious diseases all over the world. Recent studies reported an increased antibiotic resistance in Escherichia coli, primary causative agent of UTI. The resistance has emerged even to more potent antimicrobial agents like fluoroquinolones. Objectives: The present study was undertaken to evaluate the prevalence and resistance pattern of E.coli causing UTIs in patients admitted to a tertiary care hospital in South India, with reference to fluoroquinolones. Material and Methods: A total of 278 selected urine samples of urinary tract infections were processed for E.coli culture using standard methods. For these urinary E. coli isolates, susceptibility to various antibiotics including fluoroquinolones was checked by Kirby Bauer disk diffusion method according CLSI criteria. Final resistance to fluoroquinolones isolates was analyzed. Results: Out of the 278 selected UTI clinical isolates 148 (54%) showed ciprofloxacin sensitive and 130 (46%) clinical isolates are ciprofloxacin resistant. Of the 130 ciprofloxacin resistant urinary isolates of E. coli subjected to susceptibility test for increased generation of fluoroquinolone drugs, the pattern of resistance noticed as levofloxacin (2ndgeneration) 79%, gatifloxacin (3rdgeneration) 77% and moxifloxacin (4thgeneration) 75%, respectively.The fluoroquinolone resistance in UTI clinical isolates was decreasing with increasing generations of fluoroquinolone. Quinolone drug resistance in clinical isolates was increasing with age and hospitalized patients. Conclusion: Study showed an increased fluoroquinolone resistance among uropathogenic E. coli isolates of UTI. These increased antibiotic resistance trends in UTI patients indicated that it is imperative to rationalize the use of antimicrobials and to use them conservatively.
机译:背景:泌尿道感染(UTI)是全世界最常见的传染病之一。最近的研究报道,UTI的主要病原体大肠杆菌耐药性增强。甚至对更有效的抗菌剂(如氟喹诺酮类药物)也产生了耐药性。目的:本研究旨在评估氟喹诺酮类药物在南印度三级医院收治的患者中引起大肠杆菌的尿路感染的发生率和耐药性。材料和方法:使用标准方法,共处理了278个选定的尿路感染尿液样本,以进行大肠杆菌培养。对于这些尿液大肠杆菌分离株,根据CLSI标准,通过Kirby Bauer纸片扩散法检查了对各种抗生素(包括氟喹诺酮类)的敏感性。分析了最终对氟喹诺酮类药物的耐药性。结果:在278个选定的UTI临床分离株中,有148个(54%)显示对环丙沙星敏感,而130个临床分离株(46%)对环丙沙星耐药。在经过敏感性测试的130株对环丙沙星耐药的大肠杆菌尿液分离株中,发现氟喹诺酮类药物的产生增加,其中耐药性的模式分别为左氧氟沙星(第2代)79%,加替沙星(第3代)77%和莫西沙星(第4代)75%。 UTI临床分离株中氟喹诺酮耐药性随氟喹诺酮世代的增加而降低。临床分离物中喹诺酮类药物的耐药性随年龄和住院患者的增加而增加。结论:研究表明泌尿道感染的尿路致病性大肠杆菌分离株中氟喹诺酮耐药性增加。尿路感染患者中抗生素耐药性趋势的增加表明,必须合理使用抗菌药物并保守使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号